Sarcopenia and Its Associated Metabolic Profile Predict Incident Heart Failure: A Prospective Cohort Study of 267 335 Adults in the UK Biobank

Background Sarcopenia is prevalent in heart failure (HF), but its role in incident HF and underlying metabolic mechanisms remains unclear. We examined the interplay between sarcopenia phenotypes, circulating metabolic profiles, and incident HF. Methods We analyzed UK Biobank participants without baseline HF. Associations between sarcopenia phenotypes and HF incidence were assessed using Cox regression. Nuclear magnetic resonance metabolomics was used to characterize sarcopenia‐related profiles. Cox regression was applied to test metabolite–HF associations, and least absolute shrinkage and selection operator regression was further used to refine predictors. Incremental predictive value beyond clinical risk factors was evaluated using discrimination and reclassification metrics. Results During a median 15.3 years, 10 233 of 267 335 participants (mean age 56.5 ± 8.1 years; 44.6% men) developed HF. Groups with confirmed sarcopenia (n=1993) and low handgrip strength (normalized to body mass index) only (n=18 796) were associated with higher HF risk (hazard ratio [HR], 1.63 [95% CI, 1.44–1.85]; HR, 1.76 [95% CI, 1.66–1.85]) compared with the reference group, with stronger effects observed in younger adults and women. Metabolomic profiling revealed sarcopenia‐related alterations (higher glycoprotein acetyls, glucose–lactate, phenylalanine, tyrosine, 3‐hydroxybutyrate; lower omega‐3 fatty acids, docosahexaenoic acid, glycine, glutamine, histidine), which also predicted higher HF risk (Bonferroni‐adjusted P < 0.05). Selected metabolites are significant mediators and modestly improved HF prediction (15‐year net reclassification improvement 14%–15%; integrated discrimination improvement 0.9%–1.0%). Conclusions Sarcopenia, particularly reduced handgrip strength, was a strong predictor for incident HF. Lipid‐, amino acid‐, and energy metabolism–related alterations modestly improved risk prediction and partially mediated the association.

Authors

Institutions

Publication Details

Journal
Journal of the American Heart Association
Published
2026-07-17
DOI
https://doi.org/10.1161/jaha.125.047621
Primary Topic
Nutrition and Health in Aging
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sarcopenia and Its Associated Metabolic Profile Predict Incident Heart Failure: A Prospective Cohort Study of 267 335 Adults in the UK Biobank

Masoud Isanejad, Reijo Sund, Rajiv Sankaranarayanan, Manlin Zhao et al.
Journal of the American Heart Association
Nutrition and Health in Aging
article

Sarcopenia and Its Associated Metabolic Profile Predict Incident Heart Failure: A Prospective Cohort Study of 267 335 Adults in the UK Biobank

Masoud Isanejad, Reijo Sund, Rajiv Sankaranarayanan, Manlin Zhao, Daniel James Cuthbertson, Yang Chen, Ziyi Zhong, Hongyu Liu, Vanja Pekovic-Vaughan, Q X Xiang
article en

Abstract

Background Sarcopenia is prevalent in heart failure (HF), but its role in incident HF and underlying metabolic mechanisms remains unclear. We examined the interplay between sarcopenia phenotypes, circulating metabolic profiles, and incident HF. Methods We analyzed UK Biobank participants without baseline HF. Associations between sarcopenia phenotypes and HF incidence were assessed using Cox regression. Nuclear magnetic resonance metabolomics was used to characterize sarcopenia‐related profiles. Cox regression was applied to test metabolite–HF associations, and least absolute shrinkage and selection operator regression was further used to refine predictors. Incremental predictive value beyond clinical risk factors was evaluated using discrimination and reclassification metrics. Results During a median 15.3 years, 10 233 of 267 335 participants (mean age 56.5 ± 8.1 years; 44.6% men) developed HF. Groups with confirmed sarcopenia (n=1993) and low handgrip strength (normalized to body mass index) only (n=18 796) were associated with higher HF risk (hazard ratio [HR], 1.63 [95% CI, 1.44–1.85]; HR, 1.76 [95% CI, 1.66–1.85]) compared with the reference group, with stronger effects observed in younger adults and women. Metabolomic profiling revealed sarcopenia‐related alterations (higher glycoprotein acetyls, glucose–lactate, phenylalanine, tyrosine, 3‐hydroxybutyrate; lower omega‐3 fatty acids, docosahexaenoic acid, glycine, glutamine, histidine), which also predicted higher HF risk (Bonferroni‐adjusted P < 0.05). Selected metabolites are significant mediators and modestly improved HF prediction (15‐year net reclassification improvement 14%–15%; integrated discrimination improvement 0.9%–1.0%). Conclusions Sarcopenia, particularly reduced handgrip strength, was a strong predictor for incident HF. Lipid‐, amino acid‐, and energy metabolism–related alterations modestly improved risk prediction and partially mediated the association.

Journal of the American Heart Association
University of Liverpool (GB), University of Eastern Finland (FI), Aintree University Hospitals NHS Foundation Trust (GB), Liverpool Heart and Chest Hospital (GB), Aintree University Hospital (GB), Finland University (FI), Liverpool John Moores University (GB)
Gender equality
Openalex Percentile: Top 9%
Nutrition and Health in Aging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.